University Bridge Fund

Predictive analytics for sustainable smart assets. We provide advanced, big-data analytics to unlock the power of IoT across built assets that offer the ability to deliver ESG commitments, operational efficiencies, climate resilience, and environmental compliance at scale.

Atrian Medical Ltd. is an innovative Irish medical device company focused on resolving Atrial Fibrillation (AF) through a unique approach that targets the cardiac autonomic nervous system. Their technology, developed at the Mayo Clinic, utilizes non-thermal Pulsed Field Ablation (PFA) to disable hyperactive neurons responsible for arrhythmias, offering a more durable solution compared to existing therapies. With over €5M in funding and successful enrollment of 36 patients in First-In-Human trials, Atrian Medical is positioned to disrupt the growing AF market with its novel catheter designs and robust intellectual property.

Our team has dreamed of revolutionizing the audio industry since our humble beginning in Enschede, the Netherlands, in 2014. Now that we have joined Monolithic Power Systems in early 2024, we can make that dream a reality. At MPS Axign, we want everyone to be able to experience the feelings that we know what a truly great sound experience can bring. We combine our wide range of expertise—Digital Signal Processing, Analog/Mixed-Signal/Power Design, Control Systems, Embedded Software, System-Level Design, and Audio Engineering—to invent and perfect innovative technologies, and deliver high-efficiency and high-fidelity audio amplifier system solutions to our customers, a passion we share with our new MPS family. We’re excited to see and hear what we will accomplish together!

Bluedrop Medical have developed a patented system to reduce the burden of diabetic foot ulcers. There are currently almost half a billion diabetics worldwide, and it has been estimated that up to 25% will develop a foot ulcer at some point in their life. Of the millions who develop ulcers worldwide every year, hundreds of thousands will require amputation due to infection. Bluedrop Medical are combining detection technology with the Internet of Things to create a connected health system capable of identifying ulcers early, where they can be treated more effectively and cheaply.

CroíValve is an early-stage medical device company developing a unique transcatheter device to repair the tricuspid valve.

Asset tracking made simple. Danalto makes massive-scale IoT universally easy and accessible, enabling asset tracking and management across wide open spaces, both indoor and outdoor.

Founded by experts in quantum physics and semiconductors, Equal1 aims to democratise quantum computing by making it accessible and affordable with its innovative quantum silicon technology. By integrating the entire quantum computing system onto a single chip, Equal1 significantly reduces the size and cost of quantum computers, transforms their performance and scalability, and opens up a world of possibilities in sectors like pharmaceuticals, finance, materials science, and more. Equal1 is supported by funding from Atlantic Bridge (abven.com), Matterwave Ventures (matterwave.vc), Enterprise Ireland (enterprise-ireland.com), European Innovation Council (eic.ec.europa.eu), and 808 Ventures (808ventures.vc).

We enable cardiologists to save lives through exceptional decision-making accuracy.

Our mission is to improve the world by making lightning-fast suburban deliveries affordable, green, and safe. We're hiring: https://www.manna.aero/careers

We are driving the future of animal health through technology that enables the agriculture industry to target treatment based on rapid, on-site diagnostics. Helping maximize yield and reduce costs, all whilst helping to reduce environmental impact.

Neurent Medical is pioneering innovative treatments for chronic inflammatory sino-nasal diseases by targeting and disrupting hyperactive autonomic nerves that drive the underlying inflammation. Neuromark is a gentle in-office treatment for chronic rhinitis, a common condition characterized by persistent symptoms of nasal congestion, nasal drainage, and numerous other symptoms that severely impact patient quality of life.

Neurobell develops novel products for early detection and monitoring of neonatal seizures to facilitate better treatment and patient outcomes.